Optimization of In Vivo Studies by Combining Planar Dynamic and Tomographic Imaging: Workflow Evaluation on a Superparamagnetic Nanoparticles System

Figure 8

In vivo molecular screening for all tested routes with γ-eye™, for the 4 hrs and 24 hrs p.i.: (a) standard IV tail vein injection, (b) retro-orbital IV injection, (c) intratracheal installation, and (d) per rectum administration. Time point postinjection is shown on each image. All images are decay-corrected. Indicative images are shown ( for each administration route).